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        Since IL-17, also called IL-17A, was identifi  ed 
a decade ago from activated T cells, related cyto-
kines, including IL-17B, C, D, E (also called 
IL-25), and F, have been reported and consti-
tute the IL-17 cytokine family (  1, 2  ). IL-17, 
the best-studied member in this family, is a 
proinfl  ammatory cytokine that was historically 
associated with many infl  ammatory  diseases, 
such as rheumatoid arthritis, asthma, lupus, 
and allograft rejection (  1, 2  ). In vitro, mRNA 
expression of genes encoding several chemo-
kines (CCL2, CCL7, CXCL1, and CCL20  )   
and matrix metalloproteinase 3 (MMP3) and 
MMP13 was signifi  cantly up-regulated after 
IL-17 treatment (  3  ). Moreover, IL-17 and TNF-      
exhibit strong synergy in promoting infl  amma-
tory gene expression (  4  ). In vivo, overexpressing 
IL-17 in the lungs resulted in chemokine up-
regulation and tissue infi  ltration by leukocytes 
(  3  ). Conversely, inhibition of IL-17 signaling 
led to impaired host defense against bacterial 
infection (  5  ) and resistance to autoimmune dis-
eases (  3, 6  –  8  ). 
  IL-17 binds to and signals through IL-17RA, 
a member of the IL-17R family (  9  ). Recently, 
it was reported that IL-17RA might form a 
heteromeric complex with IL-17RC (  10  ). IL-17 
activates NF-     B and the mitogen-activated pro-
tein kinase pathway (  2  ). IL-6 induction by IL-17 
in mouse embryonic fi  broblasts (MEFs) is de-
pendent on TNFR-associated factor 6 (TRAF6) 
(  11  ). Recently, we identifi  ed Act1 adaptor pro-
tein as an immediate and essential signaling com-
ponent of IL-17RA (  12  ). 
  Recently, a new subset of Th cells named 
Th17 was identifi  ed (  13, 14  ). The hallmark of 
Th17 subset is the production of IL-17. Inter-
estingly, Th17 cells also express IL-17F, which 
shares the strongest homology to IL-17 (  1, 2  ). 
  IL-17   and   IL-17F   genes are localized in the 
same chromosome region, and we previously 
found that this locus undergoes chromatin re-
modeling associated with Th17 diff  erentiation 
(  15  ). Recently, an IL-17  –  IL-17F heterodimer 
was found to be expressed in Th17 cells together 
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  Although interleukin (IL) 17 has been extensively characterized, the function of IL-17F, 
which has an expression pattern regulated similarly to IL-17, is poorly understood. We 
show that like IL-17, IL-17F regulates proinfl  ammatory gene expression in vitro, and this 
requires IL-17 receptor A, tumor necrosis factor receptor  –  associated factor 6, and Act1. 
In vivo, overexpression of IL-17F in lung epithelium led to infi  ltration of lymphocytes and 
macrophages and mucus hyperplasia, similar to observations made in IL-17 transgenic mice. 
To further understand the function of IL-17F, we generated and analyzed mice defi  cient in 
IL-17F or IL-17. IL-17, but not IL-17F, was required for the initiation of experimental 
autoimmune encephalomyelitis. Mice defi  cient in IL-17F, but not IL-17, had defective 
airway neutrophilia in response to allergen challenge. Moreover, in an asthma model, 
although IL-17 defi  ciency reduced T helper type 2 responses, IL-17F  –  defi  cient mice dis-
played enhanced type 2 cytokine production and eosinophil function. In addition, IL-17F 
defi  ciency resulted in reduced colitis caused by dextran sulfate sodium, whereas IL-17 
knockout mice developed more severe disease. Our results thus demonstrate that IL-17F is 
an important regulator of infl  ammatory responses that seems to function differently than 
IL-17 in immune responses and diseases. 1064 IL-17F FUNCTION IN INFLAMMATORY RESPONSE | Yang et al.
anti  –  IL-17F (Fig. S1 A, available at http://www.jem.org/
cgi/content/full/jem.20071978/DC1), further supporting the 
specifi  city of our antibody. After Th17 diff  erentiation, almost 
all cells expressing IL-17 also expressed IL-17F (  Fig. 1 B  ), indi-
cating that they are regulated by a similar molecular mechanism. 
However, there appears to be an IL-17F single-positive popu-
lation, suggesting the existence of heterogeneous subpopula-
tions in the Th17 lineage. 
with IL-17 and IL-17F homodimers (  16, 17  ). IL-17F did not 
bind to IL-17RA in vitro (  18  ). However, an anti  –  IL-17RA 
antibody blocked IL-17F  –  mediated function, whereas IL-
17RA  –  soluble protein did not (  19  ). IL-17RC was recently 
discovered to serve as a receptor for IL-17F (  20  ). However, 
the requirements of IL-17RA or IL-17RC in IL-17F signaling 
in vivo remain unclear. 
  IL-17F was reported to induce various cytokines, chemo-
kines, and adhesion molecules in human airway epithelial 
cells, vein endothelial cells, and fi  broblasts (  21  ). IL-17F was 
found in the airways of allergic asthma patients upon allergen 
challenge (  22  ). Interestingly, a mutation in the IL-17F gene 
was shown to be associated with human asthma and chronic 
obstructive pulmonary disease (  21  ). This literature suggests a 
linkage of IL-17F with human asthma. To analyze the function 
of IL-17F in airway infl  ammation, adenoviral infection (  23  ) 
or lipofectamine-mediated gene transfer (  24  ) were adopted 
to acutely overexpress IL-17F in vivo, which resulted in the 
pulmonary recruitment of neutrophils. 
  In our current study, we have analyzed the expression, 
function, and signaling mechanisms of IL-17F. We demon-
strate that IL-17  –  expressing T cells also produce IL-17F 
protein. IL-17F regulates the expression of infl  ammatory 
chemokines and cytokines, which is dependent on IL-17RA, 
Act1, and TRAF6 proteins. Lung-specifi  c overexpresssion of 
IL-17F in mice leads to infi  ltration of lymphocytes and mac-
rophages and mucus production. The examination of IL-17  –   
and IL-17F  –  defi  cient animals in multiple models has revealed 
the distinct requirements of these two genes in diff  erent in-
fl  ammatory responses. Thus, IL-17F plays a critical role in 
the regulation of infl  ammatory reactions. 
    RESULTS   
  Expression of IL-17F protein in IL-17  –  expressing T cells 
  Although IL-17F has been shown to be coexpressed with 
IL-17 in Th17 cells, whether other IL-17  –  expressing T cells 
in vivo also express IL-17F has not been clear. To allow mea-
surement of IL-17F protein expression, we prepared a biologi-
cally active IL-17F  –  Ig fusion protein; we observed IL-6 or 
CXCL1 production in MEFs and peritoneal macrophages after 
IL-17F  –  Ig treatment (unpublished data). A polyclonal anti-
body against IL-17F was raised in rabbits. After affi   nity puri-
fi  cation, we fi  rst tested the polyclonal antibody by intracellular 
staining of 293T cells transfected with a mouse IL-17F ex-
pression vector. Anti  –  IL-17F stained IL-17F but not the vector 
transfectant (  Fig. 1 A  ).   Moreover, this polyclonal antibody 
did not stain 293T cells expressing IL-17 (  Fig. 1 A  ). Thus, the 
antibody we raised appears to be specifi  c for IL-17F. 
  To analyze IL-17F protein expression in diff  erent Th 
subsets, we diff  erentiated OT-II cells into Th1, Th2, and 
Th17 lineages. Using our anti  –  IL-17F antibody for intracel-
lular staining, IL-17F protein was found expressed in Th17 
cells that also expressed IL-17 but not in Th1 or Th2 cells 
(  Fig. 1 B  ). The protein expression of IL-17F was consistent 
with its mRNA expression (unpublished data). Excessive 
amounts of IL-17 inhibited staining by anti  –  IL-17 but not 
    Figure 1.         IL-17F is produced by IL-17  –  expressing T cells.   (A)  293T  cells 
transfected with pcDNA  –  IL-17 or pcDNA  –  IL-17F, or vector only, were fi  xed 
and stained with the indicated antibodies. (B) CD4  +   T cells from OT-II mice 
were differentiated into Th1, Th2, and Th17 lineages. On day 5 of culture, 
CD4  +   T cells were restimulated with PMA and ionomycin and stained with 
appropriate antibodies. (C) Splenocytes were activated with PMA and Ion-
omycin for 5 h, and IL-17  –   and IL-17F  –  expressing cells were assessed by 
intracellular staining on CD4  +   or  TCR       +   gates. (D) IL-17F and IL-17F  –
  expressing cells in CNS infi  ltrates of mice with EAE, and in the lamina 
propria and intestinal intraepithelial lymphocytes were analyzed by intra-
cellular staining with CD4  +   gating. CNS infi  ltrates were isolated from 
  perfused mice on day 12 after the second immunization. Data are repre-
sentative of at least two independent experiments with similar results 
(percentages are shown).     JEM VOL. 205, May 12, 2008 
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lamina propria and intestinal intraepithelium expressed IL-17F 
(  Fig. 1 D  ), but in these tissues, there existed a lot more IL-17 
single-positive cells than Th17 cells generated in vitro and 
recovered from the CNS. Thus, analysis of IL-17F protein ex-
pression has revealed that IL-17F is generally coexpressed 
with IL-17 in T cells and has suggested the possibility of dif-
ferential ratios of these two cytokines in diff  erent T cell states 
or in diff  erent tissues. 
  IL-17F regulates infl  ammatory gene expression 
via IL-17RA, Act1, and TRAF6 
  We previously used a microarray analysis to identify the 
molecular targets of IL-17 and observed the up-regulation 
of chemokines and MMPs by IL-17 (  3  ). To address the bi-
ological function of IL-17F, we fi  rst treated MEFs with IL-
17F. We found that IL-17F induced   CXCL1  ,   IL-6  ,   CCL2  , 
  CCL7  , and   MMP13  , similar to the action of IL-17 (  Fig. 2 A  ).   
The levels of gene expression induced by IL-17F were 
  We also examined IL-17F expression in vivo. In addition 
to CD4  +   T cells, it has been reported that IL-17 is also pro-
duced by            T cells (  25  ). Also, during   Mycobacterium tuberculosis   
infection, IL-17 production seems to be dominated by            
T cells (  26  ). In agreement with these studies, we found that 
splenic CD4  +   and            T cells expressed IL-17 upon activation 
(  Fig. 1 C  ). As seen in in vitro  –  generated Th17 cells, IL-17F 
was coexpressed with IL-17 in these cells, though there were 
some IL-17 single-positive cells. 
  In addition to Th17 cells generated in vitro, IL-17F was 
coexpressed with IL-17 in CD4  +   T cells from the central 
nervous systems (CNS) of mice subject to the experimental 
autoimmune encephalomyelitis (EAE) model (  Fig. 1 D  ). In-
terestingly, most of the T cells that expressed IL-17F also 
expressed IL-17, and there were few IL-17 or IL-17F single-
positive cells. IL-17  +   T cells have also been found constitutively 
in the lamina propria, dependent on IL-21, ROR     t, and 
ROR      (  27  –  29  ). We found that IL-17  hi   CD4  +   T cells in the 
    Figure 2.         IL-17F induces proinfl  ammatory cytokines and chemokines in vitro via IL-17RA, TRAF6, and Act1.   (A) MEFs were treated with 
100 ng/ml IL-17 and IL-17F, and RNA samples were analyzed for expression of the indicated genes using real-time PCR. (B) MEFs from WT and IL-17RA KO 
mice were treated with 100 ng/ml IL-17 or IL-17F. After overnight incubation, cell supernatants were subjected for ELISA. After administration of recom-
binant IL-17 and IL-17F in WT and IL-17RA KO mice, neutrophil numbers were counted. The results shown are averaged from three animals in each group. 
(C) WT and TRAF6-defi  cient MEFs were treated with cytokines overnight. Culture supernatants were subjected for ELISA. (D) Real-time PCR was performed 
using cDNAs from WT and Act1-defi  cient MEFs treated with the indicated cytokines. p-values were calculated between cytokine treatment and medium 
alone (A) or between the groups indicated by a horizontal line (B  –  D) using an unpaired Student  ’  s   t   test. The experiments were repeated two to three times 
with consistent results. Results are mean   ±   SD. **, P   <   0.005.     1066 IL-17F FUNCTION IN INFLAMMATORY RESPONSE | Yang et al.
Moreover, thymic stromal lymphopoietin, a molecule in-
volved in allergic asthma and atopic dermatitis (  30  ), was in-
duced by both IL-17 and IL-17F (  Fig. 2 A  ). Because thymic 
stromal lymphopoietin is a potent inducer of Th2 responses, 
typically more moderate than IL-17 at the concentration 
used (100 ng/ml). A detailed dose comparison of IL-17 
versus IL-17F in IL-6 induction in MEFs also revealed 
that IL-17 is more potent than IL-17F (unpublished data). 
    Figure 3.         CC10  –  IL-17F mice develop lung infl  ammation and mucus hyperplasia.   (A) MLE12 were treated with 100 ng/ml IL-17F for 4 h and sub-
jected to real-time PCR analysis. (B) Schematic illustration of the construct in the IL-17F transgenic mice. hGH, human growth hormone. (C) RT-PCR de-
tection of IL-17 and IL-17F mRNA in the lung. (D) Immunohistochemistry of lung sections from IL-17F transgenic mice. Frozen lung tissues were stained 
with CD4, CD8, B220, and CD11C. (E and F) H  &  E staining of lung sections from 5  –  7-mo-old IL-17F transgenic mice. High power magnifi  cation shows the 
accumulation of mixed infl  ammatory cells, macrophages, and Charcot-Leyden  –  like crystals. (G) PAS staining of transgenic mouse lung shows mucus 
overproduction. (H) RT-PCR of homogenized lung from IL-17F transgenic mice and age-matched WT. Data shown were repeated at least twice with simi-
lar results. Results are mean   ±   SD. Bars: (D and E) 100   μ  m; (F and G) 300   μ  m.     JEM VOL. 205, May 12, 2008 
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our result suggests a cross-regulatory mechanism of diff  er-
ent Th subsets. 
  To address which molecules may be used by IL-17F to 
initiate the signaling cascade, we fi  rst prepared MEFs from 
IL-17RA  –  defi  cient mice. Because TNF-       –   or IL-1       –  medi-
ated IL-6 or CXCL1 productions were normal in IL-17RA  –
  defi  cient  fi   broblasts, IL-17 and IL-17F eff   ects were both 
impaired in these cells (  Fig. 2 B  ). Moreover, injection of IL-
17 or IL-17F into mouse peritoneum resulted in the recruit-
ment of neutrophils within 4 h ( Fig. 2 B ). In IL-17RA –  defi  cient 
mice, however, IL-17 and IL-17F both lost their ability to re-
cruit neutrophils (  Fig. 2 B  ). These results indicate that IL-
17RA is required for IL-17F as well as IL-17 signaling in vitro 
and in vivo. 
  IL-17 and IL-25 both use TRAF6 as their signaling inter-
mediate (  11, 31  ). Recently we reported Act1 as an immediate 
adaptor protein downstream of IL-17RA (  12  ). We tested the 
requirement of these molecules in IL-17F  –  induced infl  am-
matory gene expression. Induction of CXCL1 was impaired 
in TRAF6       /       MEFs upon IL-17F treatment (  Fig. 2 C  ). Also, 
although WT MEFs up-regulated the expression of IL-6, 
CXCL-1, and the transcriptional regulators CCAAT/en-
hancer binding protein       and I     B      upon IL-17F treatment, 
Act1-defi  cient MEFs did not (  Fig. 2 D  ). Our results thus in-
dicate that similar to IL-17, IL-17F requires both Act1 and 
TRAF6 for its signal transduction leading to infl  ammatory 
gene expression. 
  IL-17F overexpression induces airway infl  ammation 
  IL-17F thus uses similar signaling mechanisms as IL-17 to 
regulate similar downstream genes. Because IL-17F has been 
implicated in airway infl  ammation, we treated the mouse 
lung epithelial cell line MLE12 with IL-17F. IL-17F induced 
several chemokines in MLE12, as we found in MEFs (  Fig. 
3 A  ).   To understand the chronic eff  ects of IL-17F function 
in vivo  ,   we generated lung-specifi  c transgenic mice that selec-
tively overexpress IL-17F by epithelium cells using the Clara 
cell 10 (  CC10  ) gene promoter (  Fig. 3 B  ). Three founder 
lines were generated, and their off  spring exhibited greatly 
increased   IL-17F   mRNA expression in the lung tissues 
(  Fig. 3 C  ) and similar pathological symptoms. IL-17 mRNA 
expression in   IL-17F   transgenic mice remained unaff  ected 
(  Fig. 3 C  ). Transgenic mice but not their control littermates 
developed abnormal lung pathology starting at 5 mo of age. 
Often,   CC10  –  IL-17F   transgenic mice developed substantial 
infi  ltration by macrophages (  Fig. 3 E  ). Also, similar to IL-17 
transgenic mice,   IL-17F   transgenic mice exhibit peribron-
chial and perivascular infi  ltration of CD4  +   and B220  +   lym-
phocytes (  Fig. 3 D  ). However, we did not observe any 
neutrophil recruitment in transgenic mice. Occasionally, in 
severe cases, transgenic mice were found with a Charcot-
Leyden  –  like crystal structure in the airway similar to that re-
ported in the lung of IL-13 transgenic mice (  32  ) (  Fig. 3 F  ). 
Increased mucus production was observed in lung tissues 
from transgenic mice via periodic acid Schiff   (PAS) staining 
(  Fig. 3 G  ). The features of infl  ammatory pathology and mucus 
production in CC10  –  IL-17F mice are consistent with those 
observed in CC10  –  IL-17 mice (  3  ), supporting the idea that 
these two cytokines may have similar biological functions 
in vivo. Also, the infl  ammatory genes up-regulated in MLE12 
by IL-17F were also found signifi  cantly up-regulated in CC10  –
  IL-17F mice (  Fig. 3 H  ). 
  Generation of IL-17  –   and IL-17F  –  defi  cient mice 
  To determine whether IL-17 and IL-17F have distinct func-
tions in vivo, we generated and analyzed mice defi  cient in 
IL-17 or IL-17F.   IL-17    –  defi  cient mice were generated by 
gene targeting in embryonic stem cells by replacement of part 
of exon 2 with a luciferase-IRES-eGFP cassette without dis-
rupting the splicing boundary (Fig. S2, A and B, available at 
http://www.jem.org/cgi/content/full/jem.20071978/DC1). 
The loxP-fl  anked neomycin cassette was removed by cross-
ing the heterozygous mice with CMV-Cre mice, and the re-
sulting mice were intercrossed to generate homozygous KO 
mice. Compared with WT mice, IL-17 KO mice exhibited 
normal lymphoid compartments in both the thymus and spleen 
but moderately decreased percentages of CD4  +   T cells in the 
spleen (P = 0.03; Fig. S2, C and D). IL-17F KO was gener-
ated by an insertional inactivation of   IL-17F   exon 2 with an 
IRES-mRFP-polyA cassette (Fig. S3 A). After removal of 
the puromycin-resistant gene in the mouse germline, hetero-
zygous IL-17F KO mice were intercrossed to make homozy-
gous animals, and PCR analysis of tail genomic DNA was 
used to analyze the genotypes (Fig. S3 B).   IL-17F       /         mice 
developed normally. Compared with WT mice, IL-17F KO 
mice exhibited normal CD4  +  , CD8  +  , and CD4  +  CD8  +   ratios 
in the thymus, and similar CD4  +  , CD8  +  , and B220  +   popula-
tions in the spleen (Fig. S3, C and D). CD11b  +   macrophage/
granulocyte, CD11c  +  CD11b  lo   dendritic cell, and CD4  +  CD25  +   
regulatory T cell numbers were also compatible in IL-17F 
KO mice (Fig. S3 D). 
  As a fi  rst step to analyze these animals, IL-17F KO, IL-17 
KO, and WT control mice were immunized with KLH in 
CFA. 7 d after immunization, the animals were killed and 
spleens were collected and restimulated with KLH. In ELISA 
analysis, IL-17F and IL-17 could not be detected in IL-17F 
KO and IL-17 KO splenocyte cultures, respectively (  Fig. 4 A  ).   
Intracellular cytokine staining also revealed no IL-17 and 
IL-17F expression in the corresponding animals (Fig. S1 B). 
Levels of IL-17F were also reduced in IL-17 KO cells, 
whereas IL-17F defi  ciency did not lead to a substantial re-
duction of IL-17 expression (  Fig. 4 A  ). IL-22 expression lev-
els were moderately reduced in both IL-17F KO and IL-17 
KO samples (  Fig. 4 A  ). In addition to T cell responses, KLH-
specifi  c Ig levels in sera from immunized IL-17F KO, IL-17 
KO, and WT mice were determined by ELISA (  Fig. 4 B  ). Com-
pared with WT mice, IL-17  –  defi  cient mice exhibited lower 
levels of IgM, total IgG, and all IgG subclasses tested, consistent 
with a previous paper on 2,4,6-trinitrochlorobenzene  –  chal-
lenged IL-17  –  defi  cient mice (  33  ), whereas IL-17F defi  ciency 
resulted in a signifi  cant increase of IgG2a levels, though IFN-      
levels were not increased in these mice. These data suggest 1068 IL-17F FUNCTION IN INFLAMMATORY RESPONSE | Yang et al.
that IL-17F and IL-17 play important but perhaps diff  erential 
roles in humoral immunity. 
  Differential requirements of IL-17 and IL-17F 
in autoimmune responses 
  To examine the functions of IL-17 and IL-17F in vivo, we 
fi  rst used EAE, a Th17-mediated CNS infl  ammation disease 
model. EAE was induced in WT, IL-17 KO, and IL-17F KO 
mice.   IL-17    –  defi  cient mice were signifi  cantly delayed in dis-
ease onset and progression, whereas IL-17F KO mice only 
showed moderately improved recovery compared with both 
WT and IL-17 KO mice (  Fig. 5 A  ).   This indicates that IL-17 
but not IL-17F is required for the initiation of neuronal in-
fl   ammation. When we examined infi  ltrating  mononuclear 
cells in the CNS, CD4  +   cells were greatly reduced in both 
IL-17F KO and IL-17 KO compared with WT mice, whereas 
CD11b  +   cells were slightly increased in IL-17F KO animals 
(  Fig. 5 B  ). We then assessed the molecular basis for the re-
duced recruitment of T cells into the CNS in the mice defi  -
cient in IL-17F or IL-17 by real-time RT-PCR to assess 
chemokine expression in CNS tissue after induction of EAE. 
The expression of the chemokines CCL2 and CCL7 was 
greatly reduced in IL-17F KO compared with WT CNS, but 
more profoundly in IL-17 KO (  Fig. 5 C  ). CXCL1 expres-
sion was severely impaired in IL-17 KO but not in IL-17F 
KO in comparison with WT animals (  Fig. 5 C  ). To further 
understand whether IL-17F or IL-17 defi  ciency aff  ects the 
generation of autoreactive T cells, we assessed cytokine ex-
pression in splenocytes from the EAE mice upon myelin oli-
godendrocyte glycoprotein (MOG) peptide restimulation by 
ELISA. IFN-      expression levels were slightly increased in 
IL-17F KO but greatly elevated in IL-17 KO compared with 
WT cells (  Fig. 5 D  ). In comparison with WT splenocytes, 
IL-22 levels were slightly but not signifi  cantly decreased in 
IL-17 but not in IL-17F KO mice, whereas IL-17 and IL-
17F expression were not signifi  cantly altered in IL-17F KO 
and IL-17 KO, respectively. 
  To better understand the diff  erential eff  ects of IL-17 and 
IL-17F on EAE pathogenesis, we immunized mice with 
MOG in CFA and analyzed cytokine expression by intracel-
lular staining on day 7. At this early phase, the frequencies of 
IFN-       –  expressing CD4  +   T cells were elevated in the spleen 
but decreased in the draining lymph nodes in IL-17 KO 
compared with WT mice, whereas no diff  erence was found 
in cells from IL-17F KO mice (  Fig. 5 E  ). The percentages of 
IL-17  +   CD4  +   cells were slightly decreased in both the spleens 
and draining lymph nodes from IL-17F KO in comparison 
to WT mice (  Fig. 5 E  ). In IL-17 KO mice, the frequencies 
of IL-17F  +   CD4  +   cells were not altered (  Fig. 5 E  ). Our data 
thus indicate an eff  ect of IL-17 but not IL-17F defi  ciency in 
the priming phase, possibly resulting in a diff  erent distribu-
tion of IFN-       +   cells. 
  Differential functions of IL-17 and IL-17F in acute 
and chronic allergic airway responses 
  Because IL-17F has been implicated in allergic infl  ammation 
in humans and mice, we subjected WT, IL-17 KO, and IL-
17F KO mice to intranasal challenge by an allergenic fungal 
proteinase (FAP) derived from   Aspergillus oryzae   and analyzed 
these mice 18 h later. In this acute allergic response, consis-
tent with a previous report (  34  ), signifi  cant numbers of neu-
trophils were elicited by FAP in bronchoalveolar lavage fl  uid 
(BALF) from WT mice as determined by CD11b and Gr-1 
staining (  Fig. 6 A  ), or by May-Gr  ü  nwald-Giemsa staining of 
lavage cells (not depicted).   IL-17F KO mice exhibited sub-
stantially reduced numbers of neutrophils. However, IL-17 
KO mice had comparable numbers of neutrophils as the WT 
mice (  Fig. 6 A  ). Interestingly, IL-17RA KO mice had a simi-
lar reduction in neutrophils as IL-17F KO mice (  Fig. 6 A  ), 
indicating a requirement of IL-17RA in IL-17F  –  mediated 
neutrophilia in response to allergen challenge. To gain in-
sight into the molecular mechanism underlying IL-17F  –  me-
diated neutrophil recruitment, we assessed the expression of 
neutrophil-attracting chemokines in the whole lungs by real-
time PCR. Although many chemokines were elevated by 
allergen treatment in WT and two diff  erent KO mice, ex-
pression levels of   CXCL5  , a neutrophil-recruiting chemo-
kine and one of the IL-17F target genes, were signifi  cantly 
reduced in IL-17F KO but not IL-17 KO mice (  Fig. 6 B  ). 
This indicates that IL-17F may regulate neutrophil recruitment 
    Figure 4.         Analysis of T and B cell responses in IL-17 and IL-17F 
KO animals.   IL-17F KO, IL-17 KO, and WT control mice were immunized 
with KLH in CFA (three per group). 7 d later, the mice were killed and 
spleens and blood were collect. (A) Splenocytes from the immunized 
mice were restimulated with KLH for 3 d, and cytokine expression was 
measured by ELISA. (B) KLH-specifi  c antibodies were measured in the 
sera by ELISA. The sera were subject to a threefold serial dilution, and the 
antibody concentrations are shown as the mean for each group. Results 
are mean   ±   SD.     JEM VOL. 205, May 12, 2008 
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KO mice exhibited increased phenotypes of CD11b  int  SSC  lo  , 
suggesting enhanced degranulation (  Fig. 6 D  ) (  36  ). In sup-
port of this idea, RT-PCR analysis indicated that BALF cells 
from IL-17F KO mice expressed higher levels of major basic 
protein 1 and eosinophil peroxidase (  Fig. 6 D  ) but not neu-
trophil-specifi  c elastase (not depicted). These patterns were 
also observed by RT-PCR using total lung tissue RNAs 
(unpublished data). 
  Eosinophil degranulation is regulated by Th2 cytokines ( 36  ). 
We asked whether IL-17F defi  ciency might have an impact 
on type 2 cytokine expression. Lung lymph node cells from 
OVA-challenged IL-17F KO mice produced signifi  cantly 
higher levels of IL-4, IL-5, and IL-13 than cells from WT and 
IL-17 KO mice upon ex vivo OVA restimulation (  Fig. 6 E  ). 
Splenocytes from IL-17 KO mice showed a greatly re-
duced production of IL-4, IL-5, and IL-13, whereas those 
in vivo by promoting CXCL5 induction in the lung in response 
to allergen. 
  Because IL-17 and IL-17F exhibited diff  erential activities 
during innate responses to allergen challenge in the lung, we 
further investigated their roles in a chronic asthma model. 
WT, IL-17 KO, and IL-17F KO mice were immunized 
twice i.p. with OVA in aluminum hydroxide and subse-
quently challenged by intranasal administration of OVA pro-
tein in PBS. IL-17 KO mice receiving OVA had fewer BALF 
cells and eosinophils (  Fig. 6 C  ), which was consistent with 
previous studies using IL-17 or IL-17RA KO animals (  33, 
35  ). On the other hand, there was no signifi  cant diff  erence in 
total BALF cell numbers between WT and IL-17F KO mice, 
but BALF cells from IL-17F KO mice had signifi  cantly in-
creased eosinophils when compared with IL-17 KO mice 
(  Fig. 6 C  ). FACS analysis revealed that eosinophils in IL-17F 
    Figure 5.         IL-17 but not IL-17F is required for the initiation of EAE.   (A) EAE was induced in IL-17F KO, IL-17 KO, and WT control mice. Data shown 
are a combination of two independent experiments (  n   = 10 for each group). (B) Infi  ltrates in the CNS from the EAE mice were isolated after perfusion on 
day 12 after the second immunization, and CD4  +   and  CD11b +   cells were assessed by FACS. Horizontal bars indicate mean values. Data shown represent 
two independent experiments with similar results. (C) Chemokine expression in the CNS from the EAE mice was measured by real-time RT-PCR. (D) Sple-
nocytes from the EAE mice were stimulated with MOG peptide, and cytokine expression levels were measured by ELISA. Data shown represent two inde-
pendent experiments with similar results. (E) WT, IL-17 KO, and IL-17F KO mice were immunized with MOG/CFA and administered with pertussis toxin on 
the next day. 7 d after immunization, the mice were killed and IL-17  –  , IL-17F  –  , and IFN-       –  producing cells in the spleen and draining lymph nodes were 
analyzed by intracellular staining. Data shown are gated on CD4  +   cells and are averaged from three to four mice in each group. Results are mean   ±   SD. 
*, P   <   0.05; and **, P   <   0.005 using the Student  ’  s   t   test. n.s., not signifi   cant.   1070 IL-17F FUNCTION IN INFLAMMATORY RESPONSE | Yang et al.
    Figure 6.         IL-17 KO and IL-17F KO mice exhibited differential acute and chronic allergic responses.   (A) Recruitment of neutrophils by FAP. WT, 
IL-17 KO, IL-17F KO, and IL-17RA KO mice were challenged once intranasally with either PBS or OVA with FAP. 18 h later, BALF cells were collected and 
stained with Gr.1 by FACS. Data shown are a combination of two independent experiments with similar results (  n   = 6  –  8 mice per group). (B) Expression of 
chemokines. Whole-lung mRNA was collected and subjected to quantitative real-time RT-PCR. Data are expressed as the fold induction relative to PBS-
challenged animals. (C  –  E). WT, IL-17, and IL-17F KO mice were subjected to an asthma model. (C) Cellular profi  les in BAL fl  uid upon OVA challenge. Cells 
were harvested from BALF, stained by May-Gr  ü  nwald-Giemsa, and counted under a microscope. Eos, eosinophil; Lymp, lymphocyte; Mac, macrophage; 
Neu, neutrophil. Data shown represent two independent experiments with consistent results (  n   = 5). (D) Major basic protein 1 (MBP-1) and eosinophil 
peroxidase (EPO) expression in BAL cells. Real-time RT-PCR was performed using cDNA derived from BAL cells. CD11b expression in BAL cells was evalu-
ated by FACS. Statistical analysis was performed between the indicated group and WT. (E) Expression of type 2 cytokines in lung lymph nodes and spleen. 
3 d after culture in the presence of OVA, the levels of IL-4, IL-5, and IL-13 were measured by ELISA. Data shown in B, D, and E were repeated twice with 
similar results. Results are mean   ±   SD. *, P   <   0.05; and **, P   <   0.01 using the Student  ’  s   t   test. n.s., not signifi   cant.   
from IL-17F KO mice exhibited enhanced IL-5 and IL-13 
production (  Fig. 6 E  ). These analyses indicate that even though 
IL-17 positively regulates asthmatic allergic responses, especially 
Th2 cytokine production, IL-17F has a negative role and 
IL-17F defi  ciency leads to greater Th2 cytokine expression 
and enhanced eosinophil function. JEM VOL. 205, May 12, 2008 
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tissues from IL-17 KO mice exhibited the most severe epithe-
lial lesion and crypt basal separation, consistent with a previ-
ous study using an anti  –  IL-17 monoclonal antibody (  37  ). In 
colon tissues from IL-17F KO mice, only mild damage was 
observed (  Fig. 7, B and C  ). Accordingly, there are more leu-
kocytes in IL-17  –  defi  cient than WT lamina propria (  Fig. 7 B  ), 
consisting of a majority of macrophages together with neu-
trophils and lymphocytes, which was consistent with a pre-
vious study (  38  ). In a sharp contrast, IL-17F defi  ciency led to 
greatly reduced infi  ltrates in the lamina propria (  Fig. 7 B  ). 
  We investigated the molecular basis for diff  erential re-
cruitment of infl  ammatory cells in the experimental animals 
by analysis of chemokine gene expression in colons using real-
time RT-PCR. Unlike   CXCL1  , which was similarly reduced 
in IL-17 KO and IL-17F KO mice,   CCL2  ,   CCL5  , and   CCL7   
mRNA expression were elevated in IL-17  –  defi  cient mice 
upon DSS treatment when compared with WT mice, whereas 
  Differential function of IL-17 and IL-17F in dextran 
sulfate sodium (DSS)  –  induced colitis 
  The results on CNS and lung infl  ammation indicate diff  er-
ential functions of IL-17 and IL-17F that target diff  erent tis-
sues. To further ascertain this fi  nding, we subjected WT, 
IL-17 KO, and IL-17F KO mice to a colitis model induced 
by oral feeding with DSS (a compound from Gram-positive 
bacteria   Leuconostoc   species). Upon DSS treatment, WT mice 
developed acute colitis symptoms indicated by bloody diar-
rhea on days 2  –  6, with a peak on days 3  –  4 and loss of body 
weight from day 5. On day 8, the experimental mice were 
killed, and colon tissues were collected for histological and 
gene expression analysis. Compared with WT mice, IL-17 
KO mice exhibited more severe diarrhea and more blood in 
the feces with increased weight loss, whereas IL-17F KO 
mice had much milder symptoms and less weight loss (  Fig. 7 A   
and not depicted).   As revealed by histological analysis, colon 
    Figure 7.         IL-17 and IL-17F differentially regulate DSS-induced colitis.   (A) Acute colitis was induced in WT, IL-17 KO, and IL-17F KO mice by oral 
feeding of DSS (  n   = 5  –  8 per group). Weight loss during colitis progression is shown. (B) Mice with colitis were killed on day 8, and the middle segment 
of the colon was fi  xed, sectioned, and stained with H  &  E. Bar, 1 mm. (C) Clinical scores are indicated based on microscopic examination of an epithelial 
lesion in the colon. (D) Chemokine mRNA expression was assessed in colon tissues by real-time RT-PCR. Data were expressed as the relative abundance 
of Actb. The experiments were repeated at least two to three times with consistent results. Results are mean values. *, P   <   0.05; and **, P   <   0.005 using 
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found normal binding of IL-17F  –  Ig to IL-17RA       /       macro-
phages (unpublished data). Thus, IL-17RA may not directly 
mediate binding of IL-17F to the cell surface but rather may 
regulate its signaling with other receptor components. IL-17 
signaling also requires IL-17RC, which forms a complex with 
IL-17RA (  10  ). In our preliminary analysis, we found that 
siRNA reduction of IL-17RC expression in MEFs also de-
creased IL-17F  –  induced gene expression (unpublished data), 
suggesting the involvement of IL-17RC in IL-17F signaling. 
These results are consistent with a recent paper demonstrat-
ing the binding of IL-17F to IL-17RC (  20  ). Further studies 
are necessary to elucidate the receptors used by these cyto-
kines. Although IL-17 and IL-17F may potentially bind to 
diff  erent receptors on the target cells, they appear to use the 
same signaling components. In the current study, we for the 
fi  rst time show the requirements of Act1 and TRAF6 in IL-17F 
induction of downstream infl  ammatory genes. 
  In vitro  ,   IL-17F appears to have a weaker proinfl  amma-
tory function. One may predict that IL-17F may be less im-
portant than IL-17 in vivo. This may be true in the EAE 
model in which IL-17F is not required for the initiation of 
EAE with only a minor role in maintaining infl  ammation in 
the CNS. Our results using IL-17F KO mice are consistent 
with our unpublished data that anti  –  IL-17F did not amelio-
rate EAE (unpublished data). In contrast, IL-17 KO mice, 
similar to mice treated with anti  –  IL-17 (  3, 8  ), exhibited 
greatly delayed onset and progression of EAE. Thus, IL-17 is 
thus a dominating pathogenic factor in EAE. However, our 
current study using mice defi  cient in either the IL-17 or IL-
17F gene has for the fi  rst time provided a surprising insight 
into the diff  erential function of these two cytokines in im-
mune responses. During T cell priming in vivo in response to 
KLH or MOG peptide immunization, IL-17  –   but not IL-17F  –
  defi  cient mice exhibited increased IFN-      expression in the 
spleen. Because IL-17 has not been found to regulate Th cell 
diff  erentiation (  39, 44  ), this regulation may be indirect, for 
example, by acting on myeloid cells. On the other hand, IFN-      
expression was found reduced in draining lymph nodes in 
these animals, suggesting a possibility that IL-17 regulates the 
localization of Th1 cells. In IL-17F  –  defi  cient animals, IL-17 
expression was reduced in the spleen although not signifi  cantly 
in the lymph nodes. However, in the late phases of EAE, such 
a defect was not found, suggesting that IL-17F regulation of 
IL-17 expression could be overcome by chronic immune re-
sponses. Furthermore, IgG2a production was consistently up-
regulated only in IL-17F  –  defi  cient animals. Because IFN-      
production was not aff  ected signifi  cantly in the same setting, 
it is possible that IL-17F may regulate B cell responses to IFN-     , 
which is known to be important for IgG2a switching. B cells 
express the receptors for IL-17F (unpublished data). Whether 
they respond to IL-17F and what eff  ect will be caused need to 
be investigated further. Nonetheless, our data suggest diff  er-
ential but clear involvement of IL-17 and IL-17F in the early 
phases of immune responses. 
  Evidence such as its presence in asthmatic CD4 T cell 
clones (  22  ) or its mutations in asthma patients (  45  ) suggests that 
their expression was dramatically decreased in IL-17F KO 
mice (  Fig. 7 D  ). Collectively, these data suggest that in intes-
tinal infl  ammation caused by DSS, IL-17 plays a protective 
role, whereas IL-17F may exacerbate the infl  ammation. 
    DISCUSSION   
  Th17 and other IL-17 –  expressing T cells have recently emerged 
as crucial regulators of infl  ammatory responses. However, al-
though IL-17 has been relatively well studied, the function of 
IL-17F is poorly understood. In this study, we describe the ex-
pression, signaling pathway, and in vivo function of IL-17F. 
Our study for the fi  rst time indicates that although IL-17F has 
very similar regulation and function as IL-17 in vitro, analysis 
of animals defi  cient in either of the two genes has revealed their 
distinct functions in infl  ammatory responses. 
  IL-17F is expressed in Th17 cells and other types of IL-
17  –  expressing T cells in vivo. Previous papers describe simi-
lar regulation of IL-17 and IL-17F expression by cytokines 
IL-23, TGF-     , IL-6, and IL-21, as well as transcription fac-
tors ROR     t, ROR     , and STAT3 (  8, 27  –  29, 39, 40  ). More-
over, we found that   IL-17   and   IL-17F   gene promoters share 
the same pattern of chromatin remodeling in diff  erentiated 
Th17 cells (  15  ). Several conserved noncoding sequences in 
this locus, including CNS2 (  29  ), likely mediate the coordi-
nated expression of IL-17 and IL-17F. However, our analysis 
also revealed diff  erent ratios of IL-17 and IL-17F expression 
in diff  erent T cell populations in vitro and in vivo. This sug-
gests diff  erential cytokine expression in diff  erentiated Th17 
cells. What accounts for this diff  erential regulation is un-
known at this point. The biological or pathological signifi  -
cance of this regulation is also unclear. In Th2 cells, we 
previously found that the inducible co-stimulator  –  c-Maf 
pathway only controls IL-4 but not IL-5 or IL-10 expression 
in the eff  ector stage, and inducible co-stimulator defi  ciency 
selectively abrogates IL-4  –  dependent IgE production but not 
IL-5  –  mediated airway eosinophilia (  41, 42  ). Moreover, ex-
pression of IL-22 by Th17 cells appears to be more depen-
dent on IL-23 than IL-17 and IL-17F (  43  ). More studies are 
necessary in the future to comprehend the diff  erential regula-
tion of Th17 cytokines. Interestingly, our recent work re-
vealed that ROR      mutant T cells had a selective defect in 
IL-17 but not IL-17F or IL-22 production (  29  ). 
  Compared with IL-17, IL-17F has weaker activity in in-
ducing proinfl  ammatory molecules in vitro. However, this 
activity is meaningful as in vivo, transgenic overexpression of 
IL-17F led to pathological airway phenotypes. Why, then, 
do we need two similar cytokines? The situation is even more 
complex considering the heterodimeric IL-17A/F molecule 
with intermediate activity in vitro as compared with the IL-
17 and IL-17F homodimers (  16  ). One possible explanation is 
that these cytokines may diff  erentially use diff  erent cytokine 
receptors that are diff  erentially expressed or alternatively 
spliced. IL-17, IL-17F, and IL-17A/F depend on IL-17RA 
for signal transduction (  16  ). How IL-17RA mediates IL-17F 
signaling is unclear at this point. Previous literature showed 
that IL-17F did not bind to IL-17RA in vitro (  18  ). We also JEM VOL. 205, May 12, 2008 
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to generate MEFs using standard approaches.   TRAF6       /         MEFs were pro-
vided by T. Mak (University of Toronto, Toronto, Canada) and grown in 
high glucose DMEM supplemented with 10% FBS. For the measurement of 
IL-6 or CXCL1, cells were treated with cytokines overnight, and the culture 
supernatants were analyzed by ELISA. For RNA analysis, MEFs were treated 
for 4 h in serum-free DMEM before stimulation with various cytokines and 
homogenization in TRI  zol   (Invitrogen). RNA samples from IL-17F  –  treated 
  Act1  -defi  cient MEFs were provided by X. Li and C. Liu (Cleveland Clinic, 
Cleveland, OH). Lamina propria and intestinal intraepithelial lymphocytes 
were isolated from the small intestine as previously described (  47  ). 
  RT-PCR.     cDNA was synthesized using RNase H RT (Invitrogen) analyzed 
in triplicates by using iQ SYBR Green Supermix in an iCycler (both from 
Bio-Rad Laboratories). The expression levels of each gene were normalized 
to the reference gene Actb expression level using a standard curve method. 
The primer sets for real-time PCR are as follows:   IL-17F,   (F) 5     -CTGGAG-
GATAACACTGTGAGAGT-3      and (R) 5     -TGCTGAATGGCGACG-
GAGTTC-3     . Other primers were described previously (  3, 12, 36  ). 
  Recombinant cytokine administration.       IL-17R       /         and WT mice 
were administered i.p. with 0.5   μ  g of recombinant mouse IL-17 or IL-
17F (R  &  D Systems) per mouse in 500   μ  l of endotoxin-free PBS. The 
peritoneal lavage fl  uid was carefully collected after 4 h. Cell pellets were 
resuspended in PBS/EDTA and total cell numbers were counted. Diff  er-
ential cell counting was performed on cytospin preparations stained with 
May-Gr  ü  nwald-Giemsa. 
  Generation of IL-17F transgenic mice.     To generate   IL-17F   transgenic 
mice, the   CC10   promoter sequence (a gift from J. Elias, Yale University, 
New Haven, CT) was ligated to full-length mouse IL-17F cDNA followed 
by an internal ribosomal entry site (IRES)  –  GFP cassette (provided by 
K. Murphy, Washington University, St. Louis, MO). Human growth hormone 
intronic and polyadenylation sequences were inserted into the CC10  –  IL-
17F  –  IRES  –  GFP  –  pBluescript II construct using the   Bam  HI and   Not  I restric-
tion enzyme sites. The   IL-17F   transgene construct was isolated by digestion 
with   Not  I and   Sap  I and was microinjected into B6 mice at the Transgenic 
Facility at the University of Washington. Three   IL-17F   transgenic founders 
were obtained and were maintained by breeding with B6 mice. Lungs were 
infused with 4% paraformaldehyde, and sections from these samples were 
made and stained with hematoxylin and eosin (H  &  E) and PAS. For immuno-
histochemistry, the lungs were infl  ated with a 1:1 mixture of PBS/optimum 
cutting temperature (OCT) compound (Tissue-Tek; Sakura Finetek), em-
bedded in OCT, and quickly frozen in a dry ice/isopropyl alcohol bath. 
  Generation of IL-17 and IL-17F KO mice.       IL-17    –  defi  cient mice were 
generated by replacement of partial   IL-17   exon 2 with a luciferase-IRES-
eGFP cassette without disrupting splicing boundaries, using the 129/TC1 
embryonic stem cell line. The targeting vector applied NeoR as positive and 
thymidine kinase as negative selection markers. IL-17F KO was generated by 
insertion of an IRES-mRFP-polyA cassette into   IL-17F   exon 2. An Frt-
fl  anked puromycin resistance gene and a diphtheria toxin gene served as posi-
tive and negative selection markers, respectively. Targeted embryonic stem 
clones for IL-17 or IL-17F were selected and injected into C57BL/6 blasto-
cysts to generate chimeras. High percentage chimeras were bred with 
C57BL/6 for germline transmission.   IL-17  +/         mice were obtained after dele-
tion of the NeoR cassette by crossing with the CMV-Cre strain, and   IL-
17F  +/         mice were obtained after excision of the PuroR cassette by crossing 
with FLPeR strain. Homozygous KO and WT animals on the same 129   ×   
C57BL/6 F1 mixed background were bred and used in experiments. 
The genotyping primers for IL-17 KO were as follows: (F) 5     -  TCAACC-
GTTCCACGTCACCCTGGAC  -3      and (R) 5     -  TCAGCATTCAACTT-
GAGCTCTCATGC  -3     , amplifying a 299-bp WT band and/or a 414-bp 
KO band. The genotyping primers for IL-17F KO were as follows: (F) 
5     -  ACATTGCCCACCACCAGGGCTC  -3     , (R1) 5     -  CCCATGGGGAA-
CTGGAGCGGTTC  -3     , and (R2) 5     -  TTCGGCCAGTAACGTTAGG  -3     . 
IL-17F might be relevant to asthma. Our current study using 
IL-17 and IL-17F KO animals indicates that IL-17 is not re-
quired for neutrophil recruitment in innate responses to an 
allergen; instead, IL-17F appears more prominent in recruiting 
neutrophils. However, when we examined the eff  ect of IL-17 
or IL-17F defi  ciency on an asthma model, IL-17 KO mice, 
as predicted from the literature, exhibited reduced Th2 cyto-
kine expression, whereas IL-17F KO mice had enhanced 
clinic symptoms such as elevated type 2 cytokines and eosin-
ophil functions compared with WT mice. Thus, IL-17 and 
IL-17F may have opposite functions in chronic allergic airway 
diseases. The contrasting eff  ects of IL-17 and IL-17F have 
also been observed in acute experimental colitis induced by 
DSS. IL-17F KO mice were protected, whereas IL-17 defi  -
ciency increased the colon damage. At this stage, it is diffi   cult 
to comprehend the functional diff  erences of IL-17 and IL-17F 
in these models. Perhaps the receptors for them are diff  eren-
tially expressed on target cells or these cytokines transduce 
diff  erential signals that may, in turn, activate feedback anti-
infl  ammatory mechanisms. Further studies will be needed, and 
our data represent a fi  rst step toward a better understanding 
of IL-17 and IL-17F functions in vivo. 
  In summary, in addition to IL-17, IL-17F is expressed in 
Th17 cells and IL-17  –  expressing            T cells. These two cyto-
kines may use the same signaling components, such as IL-17RA, 
Act1, and TRAF6, to induce similar downstream infl  amma-
tory genes. In vivo, transgenic overexpression of IL-17 or 
IL-I7F in the lung led to similar pathological phenotypes. 
However, our analysis using mice defi  cient in either gene has 
revealed their distinct functions in diff  erent types of infl  am-
matory responses. Our results have revealed complex mecha-
nisms underlying tissue infl  ammation. A further understanding 
of these mechanisms may shed light on cytokine targeting in 
the treatment of infl  ammatory diseases such as allergic asthma 
and multiple sclerosis. 
  MATERIALS AND METHODS 
  Reagents.     Mouse IFN-     , IL-4, and IL-17 staining antibodies; IFN-     , IL-4, 
IL-17, and IL-6 ELISA antibodies; and CD4, CD8, B220, and isotype con-
trol antibodies used in immunohistochemistry analysis were purchased from 
BD Biosciences. CD11c antibody was purchased from Endogen. IL-6, 
TGF-     , IL-1     , and TNF-      were purchased from PeproTech, and LPS was 
obtained from Sigma-Aldrich. IL-23, IL-17, and IL-17F cytokines and 
ELISA antibodies for CXCL1 and IL-17F were obtained from R  &  D Sys-
tems. For the generation of IL-17F  –  Ig protein, cDNA sequences encoding 
IL-17F were amplifi  ed by PCR and cloned into the DES-Ig vector (  46  ). 
The secreted Ig fusion proteins from stably transfected S2 cells were purifi  ed 
by a protein A column after the CuSO  4   induction of fusion proteins expres-
sion. Polyclonal antibody against IL-17F was made by PRF  &  L by immuniz-
ing rabbits with purifi  ed IL-17F  –  Ig fusion proteins. 
  Transient transfection.     IL-17 and IL-17F cDNA were PCR amplifi  ed and 
cloned into the pcDNA 3.1  +   vector (Invitrogen), followed by sequencing 
confi  rmation. 293T cells were transfected by calcium phosphate transfection. 
  Cell isolation and culture.     Naive CD4  +   T cells from OT-II mice purifi  ed 
by AutoMACS (Miltenyi Biotec) were cultured at a ratio of 1:2 with irradi-
ated B6 splenic APCs. Th1, Th2, and Th17 diff  erentiation were performed as 
described previously (  39  ).   IL-17R       /         mice obtained from Amgen were used 1074 IL-17F FUNCTION IN INFLAMMATORY RESPONSE | Yang et al.
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